Mark Cuban’s Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

[ad_1] In a recent article published in the Journal of Clinical Oncology, researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug…